110 related articles for article (PubMed ID: 8879384)
1. Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study.
Polyzos A; Nikou G; Giannopoulos A; Toskas A; Kalahanis N; Papargyriou J; Michail P; Papachristodoulou A
Ann Oncol; 1996 Aug; 7(6):644-5. PubMed ID: 8879384
[No Abstract] [Full Text] [Related]
2. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
[TBL] [Abstract][Full Text] [Related]
3. Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas.
Chen JS; Lin YC; Jan YY; Liau CT
Anticancer Drugs; 2001 Apr; 12(4):339-43. PubMed ID: 11335790
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
[TBL] [Abstract][Full Text] [Related]
5. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial.
Ducreux M; Van Cutsem E; Van Laethem JL; Gress TM; Jeziorski K; Rougier P; Wagener T; Anak O; Baron B; Nordlinger B;
Eur J Cancer; 2005 Feb; 41(3):398-403. PubMed ID: 15691639
[TBL] [Abstract][Full Text] [Related]
6. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
Morizane C; Okada S; Okusaka T; Ueno H; Saisho T
Oncology; 2003; 64(4):475-6. PubMed ID: 12759549
[No Abstract] [Full Text] [Related]
8. Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer.
Eckel F; Lersch C; Assmann G; Schulte-Frohlinde E
Ann Oncol; 2000 Jun; 11(6):762-3. PubMed ID: 10942070
[No Abstract] [Full Text] [Related]
9. Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.
Lim KH; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Oncology; 2012; 83(2):57-66. PubMed ID: 22760079
[TBL] [Abstract][Full Text] [Related]
10. Second-line liposomal irinotecan plus fluorouracil and leucovorin in metastatic biliary tract cancer - Author's reply.
Yoo C;
Lancet Oncol; 2022 Jan; 23(1):e12. PubMed ID: 34973222
[No Abstract] [Full Text] [Related]
11. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study.
Kajanti M; Pyrhönen S
Am J Clin Oncol; 1994 Jun; 17(3):223-6. PubMed ID: 8192106
[TBL] [Abstract][Full Text] [Related]
12. Continuous 24-hour infusion of folinic acid does not increase the response rate of 5-fluorouracil but only the toxicity.
Tsavaris N; Tzannou I; Karvounis N; Kosmidis P
Oncology; 1992; 49(2):154-6. PubMed ID: 1574252
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
[No Abstract] [Full Text] [Related]
14. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
Lim JY; Jeung HC; Mun HS; Lee DK; Paik YH; Lee SJ; Yoon DS; Cho JY
Anticancer Drugs; 2008 Jul; 19(6):631-5. PubMed ID: 18525323
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Link KH; Pillasch J; Weindel M; Leder G; Beger HG
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1380. PubMed ID: 8854758
[No Abstract] [Full Text] [Related]
16. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.
Harvey JH; Smith FP; Schein PS
J Clin Oncol; 1984 Nov; 2(11):1245-8. PubMed ID: 6092556
[TBL] [Abstract][Full Text] [Related]
17. [The effect of combination chemotherapy to adapted to chronotherapy with 5-fluorouracil, leucovorin, mitomycin C and cisplatin in patients with gastric or colorectal cancer].
Kamoshita N; Yokomori T; Iesato H; Ohya T; Nagaoka H; Okabe T; Kato Y; Takeyoshi I; Ohwada S; Morishita Y
Gan To Kagaku Ryoho; 2000 May; 27(5):711-6. PubMed ID: 10832439
[TBL] [Abstract][Full Text] [Related]
18. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
19. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
Yano M; Tsujinaka T; Shiozaki H; Inoue M; Doki Y; Taniguchi M; Murata A; Monden M
Gan To Kagaku Ryoho; 1998 Jan; 25(1):139-42. PubMed ID: 9464342
[No Abstract] [Full Text] [Related]
20. 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma.
Seitz JF; Perrier H; Giovannini M; Capodano G; Bernardini D; Bardou VJ
J Chemother; 1998 Jun; 10(3):258-65. PubMed ID: 9669654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
